Literature DB >> 21615264

Zebrafish models to study drug abuse-related phenotypes.

Adam Stewart1, Keith Wong, Jonathan Cachat, Siddharth Gaikwad, Evan Kyzar, Nadine Wu, Peter Hart, Valerie Piet, Eli Utterback, Marco Elegante, David Tien, Allan V Kalueff.   

Abstract

Mounting evidence implicates the zebrafish (Danio rerio) as a promising model species for reward and addiction research. Modeling drug abuse-related behavior in both adult and larval zebrafish produced a wealth of clinically translatable data, also demonstrating their sensitivity to various drugs of abuse and the ability to develop tolerance. Several studies have also applied withdrawal paradigms to model the adverse effects of drug abuse in zebrafish. In this review, we summarize recent findings of a wide spectrum of zebrafish drug abuse-related behavioral and physiological phenotypes, discuss the existing challenges, and outline potential future directions of research in this field.

Entities:  

Mesh:

Year:  2011        PMID: 21615264     DOI: 10.1515/RNS.2011.011

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  41 in total

1.  A jump persistent turning walker to model zebrafish locomotion.

Authors:  Violet Mwaffo; Ross P Anderson; Sachit Butail; Maurizio Porfiri
Journal:  J R Soc Interface       Date:  2015-01-06       Impact factor: 4.118

2.  The common neural parasite Pseudoloma neurophilia causes altered shoaling behaviour in adult laboratory zebrafish (Danio rerio) and its implications for neurobehavioural research.

Authors:  S Spagnoli; J Sanders; M L Kent
Journal:  J Fish Dis       Date:  2016-07-11       Impact factor: 2.767

3.  Dopaminergic control of anxiety in young and aged zebrafish.

Authors:  Victoria Kacprzak; Neil A Patel; Elizabeth Riley; Lili Yu; Jing-Ruey J Yeh; Irina V Zhdanova
Journal:  Pharmacol Biochem Behav       Date:  2017-04-10       Impact factor: 3.533

Review 4.  Current approaches for the discovery of drugs that deter substance and drug abuse.

Authors:  Adam Yasgar; Anton Simeonov
Journal:  Expert Opin Drug Discov       Date:  2014-09-24       Impact factor: 6.098

5.  Imaging escape and avoidance behavior in zebrafish larvae.

Authors:  Ruth M Colwill; Robbert Creton
Journal:  Rev Neurosci       Date:  2011       Impact factor: 4.353

6.  Pseudoloma neurophilia: a retrospective and descriptive study of nervous system and muscle infections, with new implications for pathogenesis and behavioral phenotypes.

Authors:  Sean Thomas Spagnoli; Lan Xue; Katrina N Murray; Fidelis Chow; Michael L Kent
Journal:  Zebrafish       Date:  2015-04       Impact factor: 1.985

Review 7.  Zebrafish as an emerging model for studying complex brain disorders.

Authors:  Allan V Kalueff; Adam Michael Stewart; Robert Gerlai
Journal:  Trends Pharmacol Sci       Date:  2014-01-09       Impact factor: 14.819

Review 8.  Zebrafish models in neuropsychopharmacology and CNS drug discovery.

Authors:  Kanza M Khan; Adam D Collier; Darya A Meshalkina; Elana V Kysil; Sergey L Khatsko; Tatyana Kolesnikova; Yury Yu Morzherin; Jason E Warnick; Allan V Kalueff; David J Echevarria
Journal:  Br J Pharmacol       Date:  2017-04-05       Impact factor: 8.739

9.  Reducing the noise in behavioral assays: sex and age in adult zebrafish locomotion.

Authors:  Catelyn Philpott; Corey J Donack; Margot A Cousin; Chris Pierret
Journal:  Zebrafish       Date:  2012-12       Impact factor: 1.985

Review 10.  Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond.

Authors:  Allan V Kalueff; Michael Gebhardt; Adam Michael Stewart; Jonathan M Cachat; Mallorie Brimmer; Jonathan S Chawla; Cassandra Craddock; Evan J Kyzar; Andrew Roth; Samuel Landsman; Siddharth Gaikwad; Kyle Robinson; Erik Baatrup; Keith Tierney; Angela Shamchuk; William Norton; Noam Miller; Teresa Nicolson; Oliver Braubach; Charles P Gilman; Julian Pittman; Denis B Rosemberg; Robert Gerlai; David Echevarria; Elisabeth Lamb; Stephan C F Neuhauss; Wei Weng; Laure Bally-Cuif; Henning Schneider
Journal:  Zebrafish       Date:  2013-03       Impact factor: 1.985

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.